Hyperfine (NASDAQ:HYPR) & Positron (OTCMKTS:POSC) Head to Head Analysis

Hyperfine (NASDAQ:HYPR – Get Rating) and Positron (OTCMKTS:POSC – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, analyst recommendations, earnings and risk.

Valuation & Earnings

This table compares Hyperfine and Positron’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperfine	$1.50 million	164.11	-$64.85 million	N/A	N/A
Positron	N/A	N/A	N/A	N/A	N/A

Positron has lower revenue, but higher earnings than Hyperfine.

Insider and Institutional Ownership

95.9% of Hyperfine shares are held by institutional investors. 17.2% of Positron shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Hyperfine and Positron, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperfine	0	0	1	0	3.00
Positron	0	0	0	0	N/A

Hyperfine presently has a consensus price target of $8.00, suggesting a potential upside of 128.57%. Given Hyperfine’s higher possible upside, research analysts clearly believe Hyperfine is more favorable than Positron.

Risk and Volatility

Hyperfine has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500. Comparatively, Positron has a beta of -0.85, meaning that its stock price is 185% less volatile than the S&P 500.

Profitability

This table compares Hyperfine and Positron’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hyperfine	N/A	-60.78%	-13.81%
Positron	N/A	N/A	N/A

Summary

Hyperfine beats Positron on 5 of the 8 factors compared between the two stocks.

Hyperfine Company Profile (Get Rating)

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Positron Company Profile (Get Rating)

Positron Corp. operates as a nuclear medicine healthcare company specializing in the field of cardiac positron emission tomography imaging. The firm operates through the following segments: Medical Equipment and Radiopharmaceuticals. It provides an economical, end-to-end solution for PET myocardial perfusion imaging through complementary product integration of PET imaging systems, radiopharmaceuticals and radioisotopes. The company was founded by Roman Oliynyk on December 20, 1983 and is headquartered in Niagara Falls, NY.